Prenatal supervision kits.
A new panel of prenatal supervision kits is available: the PLGF ELISA (new marker for preelampsia), and PAPP-A ELISA, as well as the new DRG PKU Neonatal Screening Assay Kit. Preeclampsia, a disorder which only occurs during pregnancy, affects both the mother and the unborn baby in 5% to 8% of all pregnancies. The multisystemic disorder is a major cause of maternal and prenatal mortality worldwide that surfaces at the end of the second trimester of gestation after Week 15. The PLGF ELISA test kit, in combination with other circulating angiogenic factors, has been shown to be a reliable system to assess the occurrence of preeclampsia in Weeks 15 to 18 and later in the second or third trimester of the pregnancy. The DRG PLGF ELISA test showed a cut-off of 49 pg/mL as early as the 15th week of gestation.
Prenatal Supervision Kits DRG International
|Printer friendly Cite/link Email Feedback|
|Title Annotation:||Product focus|
|Publication:||Medical Laboratory Observer|
|Date:||Oct 1, 2008|
|Previous Article:||Accurate creamatocrit measure.|
|Next Article:||Prolactin assay now in USA.|